# module-5-challenge
Simulation: 'Pymaceuticals, Inc.', a new pharmaceutical company that specializes in anti-cancer medications, began screening for potential treatments for squamous cell carcinoma (SCC), a commonly occurring form of skin cancer.

Given access to the complete data from a simulated animal study.
In this study, 249 mice who were identified with SCC tumors received treatment with a range of drug regimens. 
Over the course of 45 days, tumor development was observed and measured. 
The purpose of this study was to compare the performance of Pymaceuticalsâ€™ drug of interest, Capomulin, against the other treatment regimens.
## Methods
Tasked with generating tables and figures needed for technical report of the clinical study. 
Provided a top-level summary of the study results.
